INFODIAB H E A LT H C O N S U LTAT I O N F O R P E O P L E W I T - - PowerPoint PPT Presentation

INFODIAB

H E A LT H C O N S U LTAT I O N F O R P E O P L E W I T H T Y P E 1 D I A B E T E S

INFODIAB

OUR MOTTO

A D A P T T Y P E 1 D I A B E T E S A F T E R Y O U R L I F E S T Y L E & N O T T H E O T H E R WAY A R O U N D

INFODIAB

I N F O D I A B S H E A LT H C O N S U LTAT I O N I S B A S E D O N O U R L I F E S T Y L E M O D E L W E C A L L T H E C O G W H E E L P R I N C I P L E

INFODIAB

BLOOD SUGAR REGULATION

DIET EXERCISE MINDSET

INFODIAB

COGWHEEL PRINCIPLE

DIABETIC CHALLENGES

INFODIAB

H O R M O N E D I S T U R B A N C E W E A K E N E D E F F E C T O F I N S U L I N F L U C T U AT I N G E F F E C T O F I N S U L I N C O N S E Q U E N C E S O F H Y P E R G LY C E M I A C O N S E Q U E N C E S O F H Y P O G LY C E M I A F E A R O F H Y P O G LY C E M I A T H E R A P E U T I C C O - D E P E N D E N C E M O V E M E N T F E A R I D E N T I T Y C R I S I S D E P R E S S I O N A N X I E T Y

WHAT WE DO

INFODIAB

I N D I V I D U A L B L O O D S U G A R R E G U L AT I O N S T R AT E G I E S I N D I V I D U A L - & L O W C A R B O H Y D R AT E D I E T S S T R E N G H T - & C A R D I O VA S C U L A R P E R S O N A L T R A I N I N G P S Y C H O S O C I A L S U P P O RT & U N D E R S TA N D I N G

INFODIAB’S EXPERIENCE

INFODIAB

2 0 1 6 – 2 0 1 7 R E S E A R C H I N G P H Y S I C A L E X E R C I S E A N D A 1 C I N S W E D I S H T Y P E 1 D I A B E T I C S AT M A L M Ö U N I V E R S I T Y H E A LT H C O N S U LTAT I O N C L I N I C I N M E D E O N S C I E N C E PA R K 2 0 1 7 – 2 0 1 8 L E C T U R I N G AT S TA D I O N M Ä S S A N & S T U D I E F Ö R B U N D E T V U X E N S K O L A N 2 0 1 8 M E M B E R S O F D I A B E T E S S A M V E R K A N O N L I N E E D U C AT I O N A L P L AT F O R M

GET IN CONTACT

INFODIAB

D A N I E L @ I N F O D I A B . C O M W W W. I N F O D I A B . C O M @ I N F O D I A B S O C I A L M E D I A

REFERENCES

INFODIAB

• 1. Kukko, +. M., Kimpimaki, T., Korhonen, S., Kupila, A., Simell, S., Veijola, R., ... & Knip, M. (2005). Dynamics of diabetes-associated autoantibodies in young children with human leukocyte antigen-conferred risk of type 1 diabetes recruited from the general population. The

Journal of Clinical Endocrinology & Metabolism, 90(5), 2712-2717.

• 2. Kulmala, P., Savola, K., Petersen, J. S., Vähäsalo, P., Karjalainen, J., Löppönen, T., ... & Knip, M. (1998). Prediction of insulin-dependent diabetes mellitus in siblings of children with diabetes. A population-based study. The Childhood Diabetes in Finland Study Group. Journal of

Clinical Investigation, 101(2), 327.

• 3. Atkinson, M. A., Eisenbarth, G. S., & Michels, A. W. (2014). Type 1 diabetes. The Lancet, 383(9911), 72.
• 4. American Diabetes Association. (2014). Diagnosis and classification of diabetes mellitus. Diabetes care, 37(Supplement 1), 87.
• 5. Misso, M. L., Egberts, K. J., Page, M., O'connor, D., & Shaw, J. (2010). Cochrane review: Continuous subcutaneous insulin infusion (CSII) versus multiple insulin injections for type 1 diabetes mellitus. Evidence‐Based Child Health: A Cochrane Review Journal, 5(4), 2.
• 6. Battelino, T., Conget, I., Olsen, B., Schütz-Fuhrmann, I., Hommel, E., Hoogma, R., ... & SWITCH Study Group. (2012). The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomised controlled trial. Diabetologia, 55(12),

3156.

• 7. Hu, F. B., Manson, J. E., Stampfer, M. J., Colditz, G., Liu, S., Solomon, C. G., & Willett, W. C. (2001). Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. New England journal of medicine, 345(11), 790.
• 8. Wolfsdorf, J., Glaser, N., & Sperling, M. A. (2006). Diabetic ketoacidosis in infants, children, and adolescents. Diabetes care, 29(5), 1151-1154.
• 9. Barnard, K., Thomas, S., Royle, P., Noyes, K., & Waugh, N. (2010). Fear of hypoglycaemia in parents of young children with type 1 diabetes: a systematic review. BMC pediatrics, 10(1), 7.
• 10. Unger, R. H., & Cherrington, A. D. (2012). Glucagonocentric restructuring of diabetes: a pathophysiologic and therapeutic makeover. The Journal of clinical investigation, 122(1), 4-11.
• 11. WHO. (2017). Physical activity. Available:

http://www.who.int/mediacentre/factsheets/fs385/en/ Last visited 21 may, 2018.

• 12. Colberg, R.S., Sigal, J.R., Fernhall, B., Regensteiner, G.J., Blissmer, J.B, Rubin, R.R., Chasan-Taber, L., Albright, L.A., & Braun, B. (2010). Exercise and Type 2 Diabetes. Diabetes Care. 33(12), 2692.
• 13. Folli, F., Saad, M. J., Backer, J. M., & Kahn, C. R. (1992). Insulin stimulation of phosphatidylinositol 3-kinase activity and association with insulin receptor substrate 1 in liver and muscle of the intact rat. Journal of Biological Chemistry, 267(31), 22171 - 22177.
• 14. Goodyear, L. J., Giorgino, F. R. A. N. C. E. S. C. O., Balon, T. W., Condorelli, G. E. R. O. L. A. M. A., & Smith, R. J. (1995). Effects of contractile activity on tyrosine phosphoproteins and PI 3-kinase activity in rat skeletal muscle. American Journal of Physiology-Endocrinology

And Metabolism, 268(5), 987 - E995.

• 15. Greiwe, J. S., Hickner, R. C., Hansen, P. A., Racette, S. B., Chen, M. M., & Holloszy, J. O. (1999). Effects of endurance exercise training on muscle glycogen accumulation in humans. Journal of Applied Physiology, 87(1), 222-226.
• 16. McCoy, M. I. C. H. A. E. L., Proietto, J. O. S. E. P. H., & Hargreaves, M. A. R. K. (1996). Skeletal muscle GLUT-4 and postexercise muscle glycogen storage in humans. Journal of Applied Physiology, 80(2), 411-415.
• 17. Andersen, P., & Saltin, B. (1985). Maximal perfusion of skeletal muscle in man. The Journal of physiology, 366(1), 233-249.
• 18. Bouchonville, M., Jaghab, J., Duran-Valdez, E., Schrader, R., & Schade, D. (2014). The effectiveness and risks of programming an insulin pump to counteract the dawn phenomenon in type 1 diabetes. Endocrine Practice, 1-25.
• 19. Campbell, P. J., Bolli, G. B., Cryer, P. E., & Gerich, J. E. (1985). Pathogenesis of the dawn phenomenon in patients with insulin-dependent diabetes mellitus: accelerated glucose production and impaired glucose utilization due to nocturnal surges in growth hormone secretion.

New England Journal of Medicine, 312(23), 1473-1479.

• 20. Perriello, G., De Feo, P., Torlone, E., Fanelli, C., Santeusanio, F., Brunetti, P., & Bolli, G. B. (1990). Nocturnal spikes of growth hormone secretion cause the dawn phenomenon in type 1 (insulin-dependent) diabetes mellitus by decreasing hepatic (and extrahepatic) sensitivity

to insulin in the absence of insulin waning. Diabetologia, 33(1), 52-59.

• 21. Watson, J. M., Sherwin, R. S., Deary, I. J., Scott, L., & Kerr, D. (2003). Dissociation of augmented physiological, hormonal and cognitive responses to hypoglycaemia with sustained caffeine use. Clinical Science, 104(4), 447-454.
• 22. Watson, J. M., Jenkins, E. J., Hamilton, P., Lunt, M. J., & Kerr, D. (2000). Influence of caffeine on the frequency and perception of hypoglycemia in free-living patients with type 1 diabetes. Diabetes Care, 23(4), 455-459.
• 23. Fahey AJ, Paramalingam N, Davey RJ, Davis EA, Jones TW, Fournier PA. The effect of a short sprint on postexercise whole-body glucose production and utilization rates in individuals with type 1 diabetes mellitus. J Clin Endocrinol Metab 2012: 97: 4193–4200.
• 24. Turner, D., Luzio, S., Gray, B. J., Dunseath, G., Rees, E. D., Kilduff, L. P., ... & Bracken, R. M. (2015). Impact of single and multiple sets of resistance exercise in type 1 diabetes. Scandinavian journal of medicine & science in sports, 25(1), s 100 – 107.
• 25. Yuen KC, Chong LE, Riddle MC. Influence of glucocorticoids and growth hormone on insulin sensitivity in humans. Diabet Med 2013: 30: 651–663.
• 26. Howlett K, Galbo H, Lorentsen J, Bergeron R, Zimmerman-Belsing T, Bulow J, Feldt-Rasmussen U, Kjaer M. Effect of adrenaline on glucose kinetics during exercise in adrenalectomized humans. J Physiol 1999: 519 (Pt 3): 911–921.
• 27. Wasserman DH. Regulation of glucose fluxes during exercise in the postabsorptive state. Annu Rev Physiol 1995: 57: 191–218.
• 28. Watt MJ, Hargreaves M. Effect of epinephrine on glucose disposal during exercise in humans: role of muscle glycogen. Am J Physiol Endocrinol Metab 2002: 283: 578–583.
• 29. Black LE, Swan PD, Alvar BA. Effects of intensity and volume on insulin sensitivity during acute bouts of resistance training. J Strength Cond Res 2010: 24: 1109–1116.
• 30. Campbell MD, Walker M, Trenell MI, Jakovljevic DG, Stevenson EJ, Bracken RM, Bain SC, West DJ. Large pre- and postexercise rapid-acting insulin reductions preserve glycemia and prevents early- but not late-onset hypoglycemia in patients with type 1 diabetes. Diabetes Care

2013: 36 (8): 2217–2224.

• 31. Jentjens R, Jeukendrup A. Determinants of post-exercise glycogen synthesis during short-term recovery. Sports Med 2003: 33: 117–144.

T H A N K Y O U F O R Y O U R T I M E

INFODIAB